Table 4.
Ratio of RSV-Associated Hospitalization Occurring in Children Aged Less Than 1 Year, From 1 to 2 Years, and From 3 to 4 Years
| Country | 0–2 moa | 3–5 moa | 6–11 moa | 0–11 moa,b | 12–35 moc | 36–59 moc |
|---|---|---|---|---|---|---|
| EU-28d | 36.8 | 20.0 | 18.1 | 74.9 | 20.7 | 4.4 |
| Austria | 38.5 | 19.6 | 16.0 | 74.1 | 21.6 | 4.3 |
| Belgium | 36.9 | 19.5 | 17.1 | 73.4 | 21.3 | 5.3 |
| Bulgaria | 36.3 | 21.7 | 18.9 | 76.9 | 19.4 | 3.7 |
| Croatia | 38.3 | 20.5 | 18.3 | 77.1 | 19.1 | 3.8 |
| Cyprus | 37.9 | 19.9 | 16.1 | 74.0 | 22.2 | 3.8 |
| Czech Republic | 35.8 | 19.9 | 17.9 | 73.6 | 21.8 | 4.6 |
| Denmark | 27.5 | 18.9 | 18.9 | 65.4 | 28.1 | 6.5 |
| Estonia | 36.3 | 19.4 | 18.0 | 73.6 | 21.5 | 4.9 |
| Finland | 38.1 | 21.1 | 16.3 | 75.5 | 21.2 | 3.3 |
| France | 39.4 | 19.6 | 20.8 | 79.8 | 16.5 | 3.7 |
| Germany | 37.4 | 19.9 | 18.0 | 75.3 | 20.9 | 3.8 |
| Greece | 39.2 | 21.0 | 18.1 | 78.2 | 17.8 | 4.0 |
| Hungary | 35.8 | 21.3 | 18.8 | 75.9 | 20.0 | 4.1 |
| Ireland | 30.3 | 20.3 | 19.5 | 70.1 | 25.2 | 4.7 |
| Italy | 39.9 | 20.6 | 17.9 | 78.3 | 17.7 | 4.0 |
| Latvia | 38.4 | 21.1 | 18.9 | 78.3 | 17.9 | 3.8 |
| Lithuania | 39.8 | 20.8 | 18.4 | 79.0 | 17.2 | 3.8 |
| Luxembourg | 36.8 | 18.8 | 15.3 | 70.9 | 24.5 | 4.6 |
| Malta | 34.0 | 18.7 | 18.7 | 71.4 | 23.2 | 5.4 |
| Netherlands | 43.8 | 18.4 | 15.7 | 77.8 | 13.8 | 8.4 |
| Norway | 30.5 | 19.5 | 17.2 | 67.1 | 30.6 | 2.3 |
| Poland | 38.4 | 19.6 | 17.5 | 75.4 | 20.3 | 4.3 |
| Portugal | 38.8 | 17.5 | 16.9 | 73.2 | 20.7 | 6.1 |
| Romania | 37.1 | 20.3 | 20.9 | 78.3 | 17.3 | 4.4 |
| Slovakia | 37.4 | 21.0 | 18.9 | 77.3 | 19.2 | 3.5 |
| Slovenia | 36.8 | 20.8 | 17.2 | 74.8 | 20.8 | 4.4 |
| Spain | 41.3 | 19.4 | 20.0 | 80.7 | 14.9 | 4.4 |
| Sweden | 34.1 | 19.2 | 18.3 | 71.6 | 23.0 | 5.4 |
| United Kingdom | 31.4 | 19.3 | 18.7 | 69.3 | 25.2 | 5.5 |
Data are percent; 100% is represented by all RSV-associated hospitalization occurring in children aged under 5 years.
aRSV-associated hospitalizations in this age group are estimated by also including data from France reported by Demont and colleagues [15].
bCalculated as a total of the previous 3 age groups (0–2 months, 3–5 months, 6–11 months).
cRSV-associated hospitalizations in these 2 age groups are estimated by also including data from Spain reported by Gil-Prieto and colleagues [14].
dIncludes the United Kingdom and excludes Norway.